Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by CNInvestingon Jun 06, 2016 8:27am
83 Views
Post# 24936845

RE:Some perspective

RE:Some perspectiveGreat pick Marcek, thanks!

Marcel7 wrote:

AMCo accounts for roughly 60% of CXR by sales, and roughly 80% of that is in the UK. So just under 50% in the UK. Weighted average price of AMCo's prescriptions is under 6 pounds, that is because the drugs that they mention are niche products with very little volume.

The article in question from the times is not on the front page. In fact, it was not even the top story on the NHS, or the 2nd, or the 3rd.

The top NHS story was this: 

https://www.thetimes.co.uk/edition/news/failures-cost-60-000-lives-every-year-sv2cxgt6x
On how the NHS causes 60,000 people to die each year.

The British public is far more likely to view this as NHS incompetence as anything else. Most articles about the NHS are about waste and incompetence.

It is clear that this practice was known 6 years ago, and nothing was done about it.

 



<< Previous
Bullboard Posts
Next >>